Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany - Implications for Price Discounts
Value Health
.
2014 Nov;17(7):A645.
doi: 10.1016/j.jval.2014.08.2335.
Epub 2014 Oct 26.
Authors
U Theidel
1
,
K Wahlers
1
,
T Mittendorf
1
Affiliation
1
Herescon GmbH, Hannover, Germany.
PMID:
27202316
DOI:
10.1016/j.jval.2014.08.2335
No abstract available